Last update 01 Nov 2024

Serine protease x SARS-CoV-2 3CLpro x DAAO

Basic Info

Related Targets
Serine proteaseSARS-CoV-2 3CLproDAAO

Related

1
Drugs associated with Serine protease x SARS-CoV-2 3CLpro x DAAO
Pentarlandir
Target
DAAO x SARS-CoV-2 3CLpro x Serine protease
Mechanism
DAAO inhibitors [+2]
Active Org.
SyneuRx International (Taiwan) Corp.SyneuRx International (Taiwan) Corp.
Originator Org.
SyneuRx International (Taiwan) Corp.SyneuRx International (Taiwan) Corp.
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with Serine protease x SARS-CoV-2 3CLpro x DAAO
NCT04911777 / Unknown statusPhase 2
A Randomized, Double-Blind, Placebo-Controlled, Proof of Principle Study of Pentarlandir™ UPPTA for the Treatment of Patients With Early COVID-19
100 Clinical Results associated with Serine protease x SARS-CoV-2 3CLpro x DAAO
Login to view more data
100 Translational Medicine associated with Serine protease x SARS-CoV-2 3CLpro x DAAO
Login to view more data
0 Patents (Medical) associated with Serine protease x SARS-CoV-2 3CLpro x DAAO
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free